Gujarat Kidney & Super Speciality IPO is a book build issue of 2,20,00,000 shares [₹250.80 crore]. The issue is a combination of a fresh issue of 2,20,00,000 shares [₹250.80 crore].
The price band for the Gujarat Kidney & Super Speciality IPO is fixed at ₹108 to ₹114 per share. The minimum application size is 1 lot [128 shares], requiring a retail investor to invest at least ₹14,592 [based on the upper price band].
Gujarat Kidney & Super Speciality IPO Details
| Open Date | December 22, 2025 |
| Close Date | December 24, 2025 |
| Issue Type | Book Built Issue |
| Face Value | ₹2 Equity Share |
| Price Band | ₹108 – ₹114 Per Share |
| Listing On | BSE, NSE |
| Issue Size | ₹250.80 Cr. [2,20,00,000 Shares] |
| Fresh Issue | ₹250.80 Cr. [2,20,00,000 Shares] |
| Offer For Sale | Not Applicable |
| Prospectus | DRHP | RHP | Anchor Investors |
Gujarat Kidney & Super Speciality IPO Reservation
| Category | Reservation | Shares Offered |
|---|---|---|
| QIB | 75.00% | 1,65,00,000 |
| NII | 15.00% | 33,00,000 |
| RII | 10.00% | 22,00,000 |
| Total | 100.00% | 2,20,00,000 |
Gujarat Kidney & Super Speciality IPO Market Lot
| Application | Lot | Shares | Amount |
| Retail Minimum | 1 | 128 | ₹14,592 |
| Retail Maximum | 13 | 1,664 | ₹1,89,696 |
| S-HNI Minimum | 14 | 1,792 | ₹2,04,288 |
| S-HNI Maximum | 68 | 8,704 | ₹9,92,256 |
| B- HNI Minimum | 69 | 8,832 | ₹10,06,848 |
Key Performance Indicator
| KPI [March 31, 2025] | Value |
| Market Capitalisation | ₹898.81 Cr. |
| P/E Ratio | 61.62x |
| EPS | ₹1.85 |
| ROE | 36.61% |
| ROCE | 37.65% |
| RoNW | 36.61% |
| Dept/Equity | 0.15 |
| EBITDA Margin | 41.12% |
| PAT Margin | 23.61% |
| Net Assets Value | ₹5.04 |
| Price To Book Value | ₹22.62 |
Gujarat Kidney & Super Speciality IPO Peer Comparison
| Company | P/E | EPS | RoNW | NAV |
| Yatharth Hospital & Trauma Care Services Limited | 55.84x | ₹14.72 | 8.13% | ₹88.05 |
| Gpt Healthcare Limited | 24.51x | ₹6.08 | 20.14% | ₹40.71 |
| Kmc Speciality Hospitals (india) Limited | 52.60x | ₹1.31 | 13.05% | ₹23.16 |
Gujarat Kidney & Super Speciality IPO Dates
| Open Date | December 22, 2025 |
| Close Date | December 24, 2025 |
| Allotment Date | December 26, 2025 |
| Refund Date | December 29, 2025 |
| Share Credit Date | December 29, 2025 |
| Listing Date | December 30, 2025 |
Gujarat Kidney & Super Speciality Limited Company Financial Report [Restated Consolidated]
| Years | Assets | Income | Expenses | Net Worth | Profit After Tax | EBITDA | Reserves And Surplus | Borrow |
|---|---|---|---|---|---|---|---|---|
| June 2025 | ₹61.59 Cr. | ₹15.27 Cr. | ₹7.78 Cr. | ₹30.56 Cr. | ₹5.40 Cr. | ₹8.63 Cr. | ₹19.42 Cr. | ₹4.03 Cr. |
| March 2025 | ₹55.34 Cr. | ₹40.40 Cr. | ₹27.63 Cr. | ₹25.71 Cr. | ₹9.50 Cr. | ₹16.55 Cr. | ₹14.57 Cr. | ₹3.88 Cr. |
| March 2024 | ₹20.53 Cr. | ₹5.48 Cr. | ₹3.21 Cr. | ₹10.80 Cr. | ₹1.71 Cr. | ₹1.95 Cr. | ₹10.60 Cr. | ₹1.94 Cr. |
| March 2023 | ₹3.87 Cr. | ₹0.00 Cr. | ₹0.01 Cr. | ₹0.37 Cr. | ₹-0.01 Cr. | ₹-0.01 Cr. | ₹0.17 Cr. | — |
Company Promoters
- Dr. Pragnesh Yashwantsinh Bharpoda
- Dr. Bhartiben Pragnesh Bharpoda
- Dr. Yashwantsingh Motisinh Bharpoda
- Anitaben Yashwantsinh Bharpoda
| Holding Pre Issue | 99.10% | 5,68,43,250 Shares |
| Holding Post Issue | 71.45% | 7,88,43,250 Shares |
Gujarat Kidney & Super Speciality IPO Lead Managers
- Nirbhay Capital Services Private Limited
Gujarat Kidney & Super Speciality IPO Registrar
MUFG Intime India Private Limited
Phone: +91-22-4918 6270
Email: gujaratkidney.ipo@in.mpms.mufg.com
Website: https://linkintime.co.in/Initial_Offer/public-issues.html
About Gujarat Kidney & Super Speciality Limited
Incorporated in 2019, Gujarat Kidney and Super Speciality Limited (GKASSL) is a multispeciality healthcare provider offering secondary and tertiary medical care across multiple locations in Gujarat, India. The company focuses on delivering comprehensive and specialized healthcare services through its hospital network.
GKASSL operates a network of seven multispeciality hospitals and four pharmacies. The company has a total bed capacity of 490 beds, with 455 beds approved and 340 beds currently operational. This infrastructure supports the company’s ability to serve a wide range of patients efficiently.
The company’s hospitals are strategically located across key cities in Gujarat, including Vadodara, Godhra, Bharuch, Borsad, and Anand. Its hospital portfolio includes Gujarat Kidney and Superspeciality Hospital, Gujarat Multispeciality Hospital, Raj Palmland Hospital, Surya Hospital and ICU, Gujarat Surgical Hospital, and Ashwini Medical Centre. Additionally, the company operates Ashwini Medical Store in Anand to support its pharmacy services.
GKASSL provides secondary care services that include general medical and surgical treatments. Alongside this, the company offers tertiary care services involving complex and super-speciality surgical procedures.
Through Gujarat Superspeciality Hospital, the company delivers medical care in various disciplines such as internal medicine, general surgery, minimally invasive procedures, orthopaedics and trauma care, joint replacement surgeries, obstetrics and gynaecology, respiratory care, non-interventional cardiology, diabetology, and anaesthesiology.
As of June 30, 2025, the company employed 89 doctors, 332 nurses, and 338 other staff members. This experienced medical and support team plays a crucial role in maintaining high standards of patient care.
The company’s key strengths include its strong presence in renal sciences with established sub-superspecialities in urology, an asset-light business model focused on central Gujarat, the ability to attract and retain skilled medical professionals, and a proven track record of operational and financial growth.
Objects Of The Issue
- Proposed acquisition of Parekhs Hospital at Ahmedabad. (₹77.00 Cr.)
- Part-payment of purchase consideration for the already acquired “Ashwini Medical Centre”. (₹12.40 Cr.)
- Funding of capital expenditure requirements of the Company towards setting up of a new hospital in Vadodara. (₹30.10 Cr.)
- Buying robotics equipment for our hospital Gujarat Kidney & Super Speciality hospital in Vadodara location. (₹6.83 Cr.)
- Full or part repayment and/or prepayment of certain outstanding secured borrowings availed by the Company (₹1.20 Cr.)
- Funding inorganic growth through unidentified acquisitions and General Corporate Purposes.
- Acquisition of additional shareholding in the subsidiary namely “Harmony Medicare Private Limited” at Bharuch (₹10.78 Cr.)
Company Address
Gujarat Kidney & Super Speciality Limited
Plot No. 1, City Sarve No. 1537/A,
Jetalpur Road, Gokak Mill Compound,
Alkapuri, Vadodara – 390 020, Gujarat
Phone: +91 265 298 4800
Email: info@gujaratsuperspecialityhospital.com
Website: https://www.gujaratsuperspecialityhospital.com/
Gujarat Kidney & Super Speciality IPO FAQs
What is Gujarat Kidney & Super Speciality IPO?
Gujarat Kidney & Super Speciality IPO is a MainBoard IPO of 2,20,00,000 equity shares of the face value of ₹2 aggregating up to ₹250.80 Crores.
What are the open and close dates of the Gujarat Kidney & Super Speciality IPO?
The Gujarat Kidney & Super Speciality IPO will open on December 22, 2025 and will close on December 24, 2025.
What is the price band for Gujarat Kidney & Super Speciality IPO?
The price band for the Gujarat Kidney & Super Speciality IPO is fixed at ₹108 to ₹114 per share.
What is the issue size of the Gujarat Kidney & Super Speciality IPO?
The total issue size of Gujarat Kidney & Super Speciality IPO is ₹250.80 Cr., comprising both fresh issue and offer for sale (if applicable).
What is Gujarat Kidney & Super Speciality IPO Minimum and Maximum Lot Size?
The minimum bid is 1 Lot, 128 Shares with ₹14,592 amount while the maximum bid is 13 Lot, 1,664 shares with ₹1,89,696 for Gujarat Kidney & Super Speciality IPO.
What is Gujarat Kidney & Super Speciality IPO Investors Portion?
The investors’ portion for QIB 75%, NII 15%, RII 10% for Gujarat Kidney & Super Speciality IPO.
When will the basis of allotment for the Gujarat Kidney & Super Speciality IPO be finalized?
The Gujarat Kidney & Super Speciality IPO allotment is expected to be finalized on December 26, 2025.
When will the shares of Gujarat Kidney & Super Speciality IPO get listed?
The Gujarat Kidney & Super Speciality IPO shares are expected to be listed on the BSE and NSE on December 30, 2025.
Is the Gujarat Kidney & Super Speciality IPO a good investment?
Investment decisions depend on an individual’s financial goals and risk profile. It is advised to consult with a SEBI-registered financial advisor before making any investment decision.
| Read Also |
|---|
| Gujarat Kidney & Super Speciality IPO GMP |
| Gujarat Kidney & Super Speciality IPO Subscription |
| Gujarat Kidney & Super Speciality IPO Allotment |
Disclaimer: Readers are strongly advised to seek guidance from a qualified financial advisor before making any investment decisions. Relying solely on the content presented here for financial choices is done entirely at the reader’s own risk.
| Thank You… |
|---|